Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
Objective. To detect biomarkers that can be used to predict COVID-19 severity to identify patients with high probability of disease progression and poor prognosis. Methods. Of the 102 patients with confirmed COVID-19 who were admitted to King Fahd General Hospital, Jeddah City, Saudi Arabia, from Ju...
Saved in:
Main Authors: | Amal A. Abbas, Asma Alghamdi, Sonia Mezghani, Mourad Ben Ayed, Ahmed M. Alamori, Ghazi A. Alghamdi, Wail Bajhmom, Hanan Wajeeh, Salma S. Almutairi, Wafaa M. Radwan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/6336556 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Psychological Implications of the COVID-19 Pandemic Among Healthcare Workers: A Cross-Sectional Study
by: Wafaa S. Hamza, et al.
Published: (2025-01-01) -
Serum amyloid A protein as a predictor of severity in coronavirus disease 2019-infected Egyptian patients
by: Dalia A.E.M.A.E.R. Negm, et al.
Published: (2023-07-01) -
Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo
by: G. D. Rabinovici, et al.
Published: (2009-01-01) -
Distributed consensus-based voltage and frequency control for isolated microgrids with fault-induced delayed voltage recovery mitigation
by: Baheej Alghamdi, et al.
Published: (2025-01-01) -
Recurrent Syncope, a Clue in Amyloid Cardiomyopathy
by: Julian A. Marin-Acevedo, et al.
Published: (2018-01-01)